Profound Medical Corp. Files 6-K with Press Release
Ticker: PROF · Form: 6-K · Filed: Nov 26, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Profound Medical Corp. dropped a press release on 11/26/24, check the 6-K for details.
AI Summary
Profound Medical Corp. filed a Form 6-K on November 26, 2024, to report the issuance of a press release. The press release, attached as Exhibit 99.1, is incorporated by reference into this filing. The company is a foreign private issuer and will file its annual reports under Form 40-F.
Why It Matters
This filing indicates Profound Medical Corp. has released new information to the public, which could contain material updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing to attach a press release, with no immediate financial or operational news presented in the 6-K itself.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- November 26, 2024 (date) — Filing date and press release date
- Exhibit 99.1 (document) — Attached press release
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the issuance of a press release by Profound Medical Corp. on November 26, 2024, and to incorporate that press release by reference.
What exhibit is attached to this Form 6-K?
Exhibit 99.1, a Press Release, is attached to this Form 6-K.
Which form does Profound Medical Corp. use for its annual reports?
Profound Medical Corp. indicates it will file its annual reports under cover of Form 40-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on November 26, 2024.
Where is Profound Medical Corp. located?
Profound Medical Corp.'s principal executive office is located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-11-26 08:00:17
Filing Documents
- f6k_112624.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 12KB
- 0001171843-24-006587.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: November 26, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer